☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Insights+: EMA Marketing Authorization of New Drugs in December 2022
January 24, 2023
Helsinn Entered into an Exclusive License and Distribution Agreement with Immedica to Commercialize Akynzeo and Aloxi
January 24, 2023
REGENXBIO Initiates P-I/II Trial of RGX-202 for the Treatment of Duchenne Muscular Dystrophy
January 24, 2023
OncXerna Therapeutics Reports P-II Trial Results of Bavituximab + Pembrolizumab and New Xerna TME Panel Biomarker Data for Advance...
January 24, 2023
Hyloris Entered into an Exclusive License and Distribution Agreement with AFT Pharmaceuticals for Maxigesic IV in 9 EU Countries
January 24, 2023
Alvotech and Bioventure Receive the SFDA’s Approval of AVT02 (biosimilar, adalimumab) in Saudi Arabia
January 24, 2023
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions